Maximum levels of cross‐contamination for 24 antimicrobial active substances in non‐target feed. Part 2: Aminoglycosides/aminocyclitols: apramycin, paromomycin, neomycin and spectinomycin
Abstract The specific concentrations of apramycin, paromomycin, neomycin and spectinomycin in non‐target feed for food‐producing animals, below which there would not be an effect on the emergence of, and/or selection for, resistance in bacteria relevant for human and animal health, as well as the sp...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Wiley
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/cbe903487daa415f944a1b0fc8f24598 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:cbe903487daa415f944a1b0fc8f24598 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:cbe903487daa415f944a1b0fc8f245982021-11-23T08:30:51ZMaximum levels of cross‐contamination for 24 antimicrobial active substances in non‐target feed.
Part 2: Aminoglycosides/aminocyclitols: apramycin, paromomycin, neomycin and spectinomycin1831-473210.2903/j.efsa.2021.6853https://doaj.org/article/cbe903487daa415f944a1b0fc8f245982021-10-01T00:00:00Zhttps://doi.org/10.2903/j.efsa.2021.6853https://doaj.org/toc/1831-4732Abstract The specific concentrations of apramycin, paromomycin, neomycin and spectinomycin in non‐target feed for food‐producing animals, below which there would not be an effect on the emergence of, and/or selection for, resistance in bacteria relevant for human and animal health, as well as the specific antimicrobial concentrations in feed which have an effect in terms of growth promotion/increased yield, were assessed by EFSA in collaboration with EMA. Details of the methodology used for this assessment, associated data gaps and uncertainties, are presented in a separate document. To address antimicrobial resistance, the Feed Antimicrobial Resistance Selection Concentration (FARSC) model developed specifically for the assessment was applied. However, due to the lack of data on the parameters required to calculate the FARSC for these antimicrobials, it was not possible to conclude the assessment until further experimental data become available. To address growth promotion, data from scientific publications obtained from an extensive literature review were used. Levels in feed that showed to have an effect on growth promotion/increased yield were reported for apramycin and neomycin, whilst for paromomycin and spectinomycin, no suitable data for the assessment were available. It was recommended to carry out studies to generate the data that are required to fill the gaps which prevented the calculation of the FARSC for these four antimicrobials.EFSA Panel on Biological Hazards (BIOHAZ)Ana AllendeKonstantinos KoutsoumanisAna AllendeAvelino Alvarez‐OrdóñezDeclan BoltonSara Bover‐CidMarianne ChemalyRobert DaviesAlessandra De CesareLieve HermanFriederike HilbertRoland LindqvistMaarten NautaGiuseppe RuMarion SimmonsPanagiotis SkandamisElisabetta SuffrediniDan I AnderssonVasileios BampidisJohan Bengtsson‐PalmeDamien BouchardAude FerranMaryline KoubaSecundino López PuenteMarta López‐AlonsoSøren Saxmose NielsenAlena PechováMariana PetkovaSebastien GiraultAlessandro BrogliaBeatriz GuerraMatteo Lorenzo InnocentiErnesto LiébanaGloria López‐GálvezPaola ManiniPietro StellaLuisa PeixeWileyarticleapramycinparomomycinneomycinspectinomycinantimicrobial resistancegrowth promotionNutrition. Foods and food supplyTX341-641Chemical technologyTP1-1185ENEFSA Journal, Vol 19, Iss 10, Pp n/a-n/a (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
apramycin paromomycin neomycin spectinomycin antimicrobial resistance growth promotion Nutrition. Foods and food supply TX341-641 Chemical technology TP1-1185 |
| spellingShingle |
apramycin paromomycin neomycin spectinomycin antimicrobial resistance growth promotion Nutrition. Foods and food supply TX341-641 Chemical technology TP1-1185 EFSA Panel on Biological Hazards (BIOHAZ) Ana Allende Konstantinos Koutsoumanis Ana Allende Avelino Alvarez‐Ordóñez Declan Bolton Sara Bover‐Cid Marianne Chemaly Robert Davies Alessandra De Cesare Lieve Herman Friederike Hilbert Roland Lindqvist Maarten Nauta Giuseppe Ru Marion Simmons Panagiotis Skandamis Elisabetta Suffredini Dan I Andersson Vasileios Bampidis Johan Bengtsson‐Palme Damien Bouchard Aude Ferran Maryline Kouba Secundino López Puente Marta López‐Alonso Søren Saxmose Nielsen Alena Pechová Mariana Petkova Sebastien Girault Alessandro Broglia Beatriz Guerra Matteo Lorenzo Innocenti Ernesto Liébana Gloria López‐Gálvez Paola Manini Pietro Stella Luisa Peixe Maximum levels of cross‐contamination for 24 antimicrobial active substances in non‐target feed. Part 2: Aminoglycosides/aminocyclitols: apramycin, paromomycin, neomycin and spectinomycin |
| description |
Abstract The specific concentrations of apramycin, paromomycin, neomycin and spectinomycin in non‐target feed for food‐producing animals, below which there would not be an effect on the emergence of, and/or selection for, resistance in bacteria relevant for human and animal health, as well as the specific antimicrobial concentrations in feed which have an effect in terms of growth promotion/increased yield, were assessed by EFSA in collaboration with EMA. Details of the methodology used for this assessment, associated data gaps and uncertainties, are presented in a separate document. To address antimicrobial resistance, the Feed Antimicrobial Resistance Selection Concentration (FARSC) model developed specifically for the assessment was applied. However, due to the lack of data on the parameters required to calculate the FARSC for these antimicrobials, it was not possible to conclude the assessment until further experimental data become available. To address growth promotion, data from scientific publications obtained from an extensive literature review were used. Levels in feed that showed to have an effect on growth promotion/increased yield were reported for apramycin and neomycin, whilst for paromomycin and spectinomycin, no suitable data for the assessment were available. It was recommended to carry out studies to generate the data that are required to fill the gaps which prevented the calculation of the FARSC for these four antimicrobials. |
| format |
article |
| author |
EFSA Panel on Biological Hazards (BIOHAZ) Ana Allende Konstantinos Koutsoumanis Ana Allende Avelino Alvarez‐Ordóñez Declan Bolton Sara Bover‐Cid Marianne Chemaly Robert Davies Alessandra De Cesare Lieve Herman Friederike Hilbert Roland Lindqvist Maarten Nauta Giuseppe Ru Marion Simmons Panagiotis Skandamis Elisabetta Suffredini Dan I Andersson Vasileios Bampidis Johan Bengtsson‐Palme Damien Bouchard Aude Ferran Maryline Kouba Secundino López Puente Marta López‐Alonso Søren Saxmose Nielsen Alena Pechová Mariana Petkova Sebastien Girault Alessandro Broglia Beatriz Guerra Matteo Lorenzo Innocenti Ernesto Liébana Gloria López‐Gálvez Paola Manini Pietro Stella Luisa Peixe |
| author_facet |
EFSA Panel on Biological Hazards (BIOHAZ) Ana Allende Konstantinos Koutsoumanis Ana Allende Avelino Alvarez‐Ordóñez Declan Bolton Sara Bover‐Cid Marianne Chemaly Robert Davies Alessandra De Cesare Lieve Herman Friederike Hilbert Roland Lindqvist Maarten Nauta Giuseppe Ru Marion Simmons Panagiotis Skandamis Elisabetta Suffredini Dan I Andersson Vasileios Bampidis Johan Bengtsson‐Palme Damien Bouchard Aude Ferran Maryline Kouba Secundino López Puente Marta López‐Alonso Søren Saxmose Nielsen Alena Pechová Mariana Petkova Sebastien Girault Alessandro Broglia Beatriz Guerra Matteo Lorenzo Innocenti Ernesto Liébana Gloria López‐Gálvez Paola Manini Pietro Stella Luisa Peixe |
| author_sort |
EFSA Panel on Biological Hazards (BIOHAZ) |
| title |
Maximum levels of cross‐contamination for 24 antimicrobial active substances in non‐target feed.
Part 2: Aminoglycosides/aminocyclitols: apramycin, paromomycin, neomycin and spectinomycin |
| title_short |
Maximum levels of cross‐contamination for 24 antimicrobial active substances in non‐target feed.
Part 2: Aminoglycosides/aminocyclitols: apramycin, paromomycin, neomycin and spectinomycin |
| title_full |
Maximum levels of cross‐contamination for 24 antimicrobial active substances in non‐target feed.
Part 2: Aminoglycosides/aminocyclitols: apramycin, paromomycin, neomycin and spectinomycin |
| title_fullStr |
Maximum levels of cross‐contamination for 24 antimicrobial active substances in non‐target feed.
Part 2: Aminoglycosides/aminocyclitols: apramycin, paromomycin, neomycin and spectinomycin |
| title_full_unstemmed |
Maximum levels of cross‐contamination for 24 antimicrobial active substances in non‐target feed.
Part 2: Aminoglycosides/aminocyclitols: apramycin, paromomycin, neomycin and spectinomycin |
| title_sort |
maximum levels of cross‐contamination for 24 antimicrobial active substances in non‐target feed.
part 2: aminoglycosides/aminocyclitols: apramycin, paromomycin, neomycin and spectinomycin |
| publisher |
Wiley |
| publishDate |
2021 |
| url |
https://doaj.org/article/cbe903487daa415f944a1b0fc8f24598 |
| work_keys_str_mv |
AT efsapanelonbiologicalhazardsbiohaz maximumlevelsofcrosscontaminationfor24antimicrobialactivesubstancesinnontargetfeedpart2aminoglycosidesaminocyclitolsapramycinparomomycinneomycinandspectinomycin AT anaallende maximumlevelsofcrosscontaminationfor24antimicrobialactivesubstancesinnontargetfeedpart2aminoglycosidesaminocyclitolsapramycinparomomycinneomycinandspectinomycin AT konstantinoskoutsoumanis maximumlevelsofcrosscontaminationfor24antimicrobialactivesubstancesinnontargetfeedpart2aminoglycosidesaminocyclitolsapramycinparomomycinneomycinandspectinomycin AT anaallende maximumlevelsofcrosscontaminationfor24antimicrobialactivesubstancesinnontargetfeedpart2aminoglycosidesaminocyclitolsapramycinparomomycinneomycinandspectinomycin AT avelinoalvarezordonez maximumlevelsofcrosscontaminationfor24antimicrobialactivesubstancesinnontargetfeedpart2aminoglycosidesaminocyclitolsapramycinparomomycinneomycinandspectinomycin AT declanbolton maximumlevelsofcrosscontaminationfor24antimicrobialactivesubstancesinnontargetfeedpart2aminoglycosidesaminocyclitolsapramycinparomomycinneomycinandspectinomycin AT sarabovercid maximumlevelsofcrosscontaminationfor24antimicrobialactivesubstancesinnontargetfeedpart2aminoglycosidesaminocyclitolsapramycinparomomycinneomycinandspectinomycin AT mariannechemaly maximumlevelsofcrosscontaminationfor24antimicrobialactivesubstancesinnontargetfeedpart2aminoglycosidesaminocyclitolsapramycinparomomycinneomycinandspectinomycin AT robertdavies maximumlevelsofcrosscontaminationfor24antimicrobialactivesubstancesinnontargetfeedpart2aminoglycosidesaminocyclitolsapramycinparomomycinneomycinandspectinomycin AT alessandradecesare maximumlevelsofcrosscontaminationfor24antimicrobialactivesubstancesinnontargetfeedpart2aminoglycosidesaminocyclitolsapramycinparomomycinneomycinandspectinomycin AT lieveherman maximumlevelsofcrosscontaminationfor24antimicrobialactivesubstancesinnontargetfeedpart2aminoglycosidesaminocyclitolsapramycinparomomycinneomycinandspectinomycin AT friederikehilbert maximumlevelsofcrosscontaminationfor24antimicrobialactivesubstancesinnontargetfeedpart2aminoglycosidesaminocyclitolsapramycinparomomycinneomycinandspectinomycin AT rolandlindqvist maximumlevelsofcrosscontaminationfor24antimicrobialactivesubstancesinnontargetfeedpart2aminoglycosidesaminocyclitolsapramycinparomomycinneomycinandspectinomycin AT maartennauta maximumlevelsofcrosscontaminationfor24antimicrobialactivesubstancesinnontargetfeedpart2aminoglycosidesaminocyclitolsapramycinparomomycinneomycinandspectinomycin AT giusepperu maximumlevelsofcrosscontaminationfor24antimicrobialactivesubstancesinnontargetfeedpart2aminoglycosidesaminocyclitolsapramycinparomomycinneomycinandspectinomycin AT marionsimmons maximumlevelsofcrosscontaminationfor24antimicrobialactivesubstancesinnontargetfeedpart2aminoglycosidesaminocyclitolsapramycinparomomycinneomycinandspectinomycin AT panagiotisskandamis maximumlevelsofcrosscontaminationfor24antimicrobialactivesubstancesinnontargetfeedpart2aminoglycosidesaminocyclitolsapramycinparomomycinneomycinandspectinomycin AT elisabettasuffredini maximumlevelsofcrosscontaminationfor24antimicrobialactivesubstancesinnontargetfeedpart2aminoglycosidesaminocyclitolsapramycinparomomycinneomycinandspectinomycin AT daniandersson maximumlevelsofcrosscontaminationfor24antimicrobialactivesubstancesinnontargetfeedpart2aminoglycosidesaminocyclitolsapramycinparomomycinneomycinandspectinomycin AT vasileiosbampidis maximumlevelsofcrosscontaminationfor24antimicrobialactivesubstancesinnontargetfeedpart2aminoglycosidesaminocyclitolsapramycinparomomycinneomycinandspectinomycin AT johanbengtssonpalme maximumlevelsofcrosscontaminationfor24antimicrobialactivesubstancesinnontargetfeedpart2aminoglycosidesaminocyclitolsapramycinparomomycinneomycinandspectinomycin AT damienbouchard maximumlevelsofcrosscontaminationfor24antimicrobialactivesubstancesinnontargetfeedpart2aminoglycosidesaminocyclitolsapramycinparomomycinneomycinandspectinomycin AT audeferran maximumlevelsofcrosscontaminationfor24antimicrobialactivesubstancesinnontargetfeedpart2aminoglycosidesaminocyclitolsapramycinparomomycinneomycinandspectinomycin AT marylinekouba maximumlevelsofcrosscontaminationfor24antimicrobialactivesubstancesinnontargetfeedpart2aminoglycosidesaminocyclitolsapramycinparomomycinneomycinandspectinomycin AT secundinolopezpuente maximumlevelsofcrosscontaminationfor24antimicrobialactivesubstancesinnontargetfeedpart2aminoglycosidesaminocyclitolsapramycinparomomycinneomycinandspectinomycin AT martalopezalonso maximumlevelsofcrosscontaminationfor24antimicrobialactivesubstancesinnontargetfeedpart2aminoglycosidesaminocyclitolsapramycinparomomycinneomycinandspectinomycin AT sørensaxmosenielsen maximumlevelsofcrosscontaminationfor24antimicrobialactivesubstancesinnontargetfeedpart2aminoglycosidesaminocyclitolsapramycinparomomycinneomycinandspectinomycin AT alenapechova maximumlevelsofcrosscontaminationfor24antimicrobialactivesubstancesinnontargetfeedpart2aminoglycosidesaminocyclitolsapramycinparomomycinneomycinandspectinomycin AT marianapetkova maximumlevelsofcrosscontaminationfor24antimicrobialactivesubstancesinnontargetfeedpart2aminoglycosidesaminocyclitolsapramycinparomomycinneomycinandspectinomycin AT sebastiengirault maximumlevelsofcrosscontaminationfor24antimicrobialactivesubstancesinnontargetfeedpart2aminoglycosidesaminocyclitolsapramycinparomomycinneomycinandspectinomycin AT alessandrobroglia maximumlevelsofcrosscontaminationfor24antimicrobialactivesubstancesinnontargetfeedpart2aminoglycosidesaminocyclitolsapramycinparomomycinneomycinandspectinomycin AT beatrizguerra maximumlevelsofcrosscontaminationfor24antimicrobialactivesubstancesinnontargetfeedpart2aminoglycosidesaminocyclitolsapramycinparomomycinneomycinandspectinomycin AT matteolorenzoinnocenti maximumlevelsofcrosscontaminationfor24antimicrobialactivesubstancesinnontargetfeedpart2aminoglycosidesaminocyclitolsapramycinparomomycinneomycinandspectinomycin AT ernestoliebana maximumlevelsofcrosscontaminationfor24antimicrobialactivesubstancesinnontargetfeedpart2aminoglycosidesaminocyclitolsapramycinparomomycinneomycinandspectinomycin AT glorialopezgalvez maximumlevelsofcrosscontaminationfor24antimicrobialactivesubstancesinnontargetfeedpart2aminoglycosidesaminocyclitolsapramycinparomomycinneomycinandspectinomycin AT paolamanini maximumlevelsofcrosscontaminationfor24antimicrobialactivesubstancesinnontargetfeedpart2aminoglycosidesaminocyclitolsapramycinparomomycinneomycinandspectinomycin AT pietrostella maximumlevelsofcrosscontaminationfor24antimicrobialactivesubstancesinnontargetfeedpart2aminoglycosidesaminocyclitolsapramycinparomomycinneomycinandspectinomycin AT luisapeixe maximumlevelsofcrosscontaminationfor24antimicrobialactivesubstancesinnontargetfeedpart2aminoglycosidesaminocyclitolsapramycinparomomycinneomycinandspectinomycin |
| _version_ |
1718416850897862656 |